Warning: The NCBI web site requires JavaScript to function. more...
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.
Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY.
Malar J. 2009 Nov 17;8:257.
Related citations
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
Souares A, Lalou R, Sene I, Sow D, Le Hesran JY.
Malar J. 2009 Jun 4;8:118.
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
Trans R Soc Trop Med Hyg. 2008 Aug;102(8):751-8.
Child age or weight: difficulties related to the prescription of the right dosage of antimalarial combinations to treat children in Senegal.
Souares A, Lalou R, Senghor P, Le Hesran JY.
Trans R Soc Trop Med Hyg. 2010 Feb;104(2):104-9. Epub 2009 Aug 27.
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
Aubouy A, Bakary M, Keundjian A, Mbomat B, Makita JR, Migot-Nabias F, Cot M, Le Bras J, Deloron P.
Antimicrob Agents Chemother. 2003 Jan;47(1):231-7.
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G.
Bull World Health Organ. 2002;80(7):538-45.
Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.
Sarrassat S, Lalou R, Cissé M, Le Hesran JY.
Malar J. 2011 Sep 29;10:285.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Mbacham WF, Evehe MS, Netongo PM, Ateh IA, Mimche PN, Ajua A, Nji AM, Irenee D, Echouffo-Tcheugui JB, Tawe B, Hallett R, Roper C, Targett G, Greenwood B.
Malar J. 2010 Jan 27;9:34.
Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
Menard D, Madji N, Manirakiza A, Djalle D, Koula MR, Talarmin A.
Am J Trop Med Hyg. 2005 May;72(5):581-5.
Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).
Munier A, Diallo A, Cot M, Ndiaye O, Arduin P, Chippaux JP.
Malar J. 2009 Apr 27;8:83.
[Combined antimalarial therapy using artemisinin].
Majori G.
Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K, Maiga H, Newman RD, McMorrow ML, Hoppe A, Yattara O, Traore H, Kone Y, Guirou EA, Saye R, Traore B, Djimde A, Doumbo OK.
Malar J. 2009 Jan 7;8:5.
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
Nsimba SE.
J Ethnobiol Ethnomed. 2006 Jan 10;2:5.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG.
Malar J. 2009 Aug 26;8:204.
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C.
Trop Med Int Health. 2006 Oct;11(10):1503-11.
Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
Cairns M, Cisse B, Sokhna C, Cames C, Simondon K, Ba EH, Trape JF, Gaye O, Greenwood BM, Milligan PJ.
Antimicrob Agents Chemother. 2010 Mar;54(3):1265-74. Epub 2010 Jan 11.
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ.
Lancet. 2005 Apr 23-29;365(9469):1474-80.
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C, Gustafsson LL, Aguttu C, Anokbonggo WW, Ogwal-Okeng JW, Chiria J, Hellgren U.
Acta Trop. 2006 Nov;100(1-2):142-50. Epub 2006 Nov 20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on